LEXEO Therapeutics LLC
Reshaping heart health through pioneering genetic medicine
LEXEO Therapeutics LLC was founded in 2018, is headquartered in New York, United States, and lists 1–10 employees.
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- lexeotx.com
About
LEXEO Therapeutics is a clinical-stage genetic medicines company dedicated to transforming cardiovascular and CNS disease treatment through AAV-mediated gene therapy. Its pipeline targets inherited cardiac conditions including Friedreich's ataxia cardiomyopathy, arrhythmogenic cardiomyopathy, and APOE4-associated Alzheimer's disease. The company is publicly traded on NASDAQ (LXEO) and is headquartered in New York City.
Summary
LEXEO Therapeutics LLC is a Biotech company based in New York, United States, founded in 2018. It lists 1–10 employees.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lexeo-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/lexeo-therapeutics-llc" alt="LEXEO Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>